compound semaglutide going away FDA restricts non-approved compounded GLP-1 weight loss products The Semaglutide Shortage Is Ending:

How can I still maintain weight loss

The duration of action of regular & NPH insulin increases at higher doses (adapted from Nolte, 2009)

[10] 38% complain of decreased vision, 9% report photopsias, 7% floaters and 6% peripheral vision loss

Similarly, competitor Novo Nordisk recently dropped the price of its weight loss drug, Wegovy

Improved metabolic signaling restores energy production, nutrient partitioning, and blood sugar stability all major factors in training consistency and mood

Clinical trials have demonstrated substantial weight loss outcomes with tirzepatide, with patients losing an average of 20-22% of their body weight at the highest dose (15 mg weekly)